Market Tracker

03/26 6:00pm ET

Pernix Therapeutics Holdings Inc (NASDAQ:PTX)

During the Trading Day
10.30 +0.62 / +6.40%
As of 4:14pm ET
Day’s Change
During After-Hours   Switch to standard view »
10.30 0.00 / 0.00%
 
Volume: 2.0K

Today’s Trading

Previous close9.68
Today’s open9.91
Day’s range9.72 - 10.37
Volume731,831
Average volume (3 months)613,654
Market cap$371.6M
Dividend yield--
Data as of 4:14pm ET, 03/26/2015

Growth & Valuation

Earnings growth (last year)-32.86%
Earnings growth (this year)+33.06%
Earnings growth (next 5 years)+13.60%
Revenue growth (last year)+43.45%
P/E ratioNM
Price/Sales2.92
Price/Book4.44

Competitors

 Today’s
change
Today’s
% change
SGYPSynergy Pharmaceutic...+0.30+7.72%
VNDAVanda Pharmaceutical...+0.16+1.78%
DERMDermira Inc+1.28+8.74%
FLKSFlex Pharma Inc+0.40+2.00%
Data as of 3:59pm ET, 03/26/2015

Financials

Next reporting dateMay 18, 2015
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$121.7M
Annual profit (last year)-$35.3M
Net profit margin-28.98%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman, President &
Chief Executive Officer
Douglas L. Drysdale
Chief Operating Officer
Terence S. Novak
Corporate headquarters
Morristown, New Jersey

Forecasts